Physician profile
Steven J Saathoff
NPI 1801883426
$2,633.58
in general payments reported to CMS, 2019-2025
37 companies · $906 in 2025
The $906 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.65 · 2020: $43.67 · 2021: $47.77 · 2022: $153 · 2023: $335 · 2024: $1,117 · 2025: $906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,259 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,258.55 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $529.40 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $355.30 | 2023-2025 | |
| Lilly USA, LLC | $261.92 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Astellas Pharma US INC | $189.58 | 2023-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $186.64 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $104.17 | 2024-2025 | |
| Abbott Laboratories | $98.46 | 2022-2024 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.82 | 2023-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $69.94 | 2024 | |
| Nestle Healthcare Nutrition INC. | $63.91 | 2023 | |
| Merck Sharp & Dohme LLC | $63.20 | 2024-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Seqirus USA INC | $52.03 | 2025 | Fluad, Flucelvax |
| Itamar Medical INC | $50.18 | 2024 | Watchpatone |
| Viiv Healthcare Company | $48.41 | 2025 | Apretude |
| Takeda Pharmaceuticals U.S.A., INC. | $44.16 | 2024 | Eohilia, Trintellix |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Saathoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.